Effects of hyperoxia on oxygen-related inflammation with a focus on obesity

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  González Muniesa, Pedro ^a,b,c   Garcia Gerique, Laura ^a   Quintero, Pablo ^d   Arriaza, Suyen ^a   Lopez Pascual, Amaya ^a   Martinez, J Alfredo ^a,b,c  

^a UNIVERSITY OF NAVARRA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Instituto de Investigación Sanitaria de Navarra   (Spain)

^d PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

NUTRITION; OXYGEN; OXYGENATION; PATHOLOGY; TISSUE;

BENEFICIAL EFFECTS; BIOLOGICAL RESPONSE; DELETERIOUS EFFECTS; HYPERBARIC OXYGENATION; INFLAMMATORY PROCESS; OXYGEN CONCENTRATIONS; OXYGEN PARTIAL PRESSURE; TISSUE OXYGENATION;

TISSUE HOMEOSTASIS;

OXYGEN; CYTOKINE;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ANTIINFLAMMATORY ACTIVITY; CELL PROTECTION; CHRONIC INFLAMMATION; HUMAN; HYPERBARIC OXYGEN; HYPEROXIA; HYPERTENSION; INFLAMMATION; NEUROPROTECTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXYGEN CONCENTRATION; OXYGEN SUPPLY; OXYGEN TENSION; OXYGEN THERAPY; REVIEW; SLEEP DISORDERED BREATHING; ANIMAL; GENETICS; HYPERBARIC OXYGEN THERAPY; HYPOXIA; METABOLISM; PATHOLOGY;

ADIPOSE TISSUE; ANIMALS; CYTOKINES; HUMANS; HYPERBARIC OXYGENATION; HYPOXIA; INFLAMMATION; OBESITY; OXYGEN;

EID: 85036589722     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/8957827     Document Type: Review

References (128)

1. M. F. Gregor and G. S. Hotamisligil, "Infammatory mechanisms in obesity," Annual Review of Immunology, vol. 29, pp. 415-445, 2011.
2. C. N. Lumeng and A. R. Saltiel, "Infammatory links between obesity and metabolic disease," The Journal of Clinical Investigation, vol. 121, no. 6, pp. 2111-2117, 2011.
3. Q. He, Z. Gao, J. Yin, J. Zhang, Z. Yun, and J. Ye, "Regulation of HIF-1β activity in adipose tissue by obesity-associated factors: adipogenesis, insulin, and hypoxia," American Journal of Physiology-Endocrinology and Metabolism, vol. 300, no. 5, pp. E877-E885, 2011.
4. R. Samper-Ternent and S. Al Snih, "Obesity in older adults: epidemiology and implications for disability and disease," Reviews in Clinical Gerontology, vol. 22, no. 1, pp. 10-34, 2012.
5. K. M. Flegal, M. D. Carroll, C. L. Ogden, and L. R. Curtin, "Prevalence and trends in obesity among US adults, 1999-2008," Journal of the American Medical Association, vol. 303, no. 3, pp. 235-241, 2010.
6. P. Hossain, B. Kawar, and M. El Nahas, "Obesity and diabetes in the developing world-a growing challenge," The New England Journal of Medicine, vol. 356, no. 3, pp. 213-215, 2007.
7. G. A. Stevens, G. M. Singh, Y. Lu et al., "National, regional, and global trends in adult overweight and obesity prevalences," Population Health Metrics, vol. 10, no. 1, article 22, 2012.
8. M. Ng, T. Fleming, M. Robinson, and et al, "Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013," The Lancet, vol. 384, no. 9945, pp. 746-781, 2014.
9. F. I. Milagro, M. L. Mansego, C. De Miguel, and J. A. Martínez, "Dietary factors, epigenetic modifcations and obesity outcomes: progresses and perspectives," Molecular Aspects of Medicine, vol. 34, no. 4, pp. 782-812, 2013.
10. B. L. Heitmann, K. R. Westerterp, R. J. F. Loos et al., "Obesity: lessons from evolution and the environment," Obesity Reviews, vol. 13, no. 10, pp. 910-922, 2012.
11. E. J. McAllister, N. V. Dhurandhar, S. W. Keith et al., "Ten putative contributors to the obesity epidemic," Critical Reviews in Food Science and Nutrition, vol. 49, no. 10, pp. 868-913, 2009.
12. P. Trayhurn, "Hypoxia and adipocyte physiology: implications for adipose tissue dysfunction in obesity," Annual Review of Nutrition, vol. 34, pp. 207-236, 2014.
13. P. Trayhurn and I. S. Wood, "Adipokines: infammation and the pleiotropic role of white adipose tissue," British Journal of Nutrition, vol. 92, no. 3, pp. 347-355, 2004.
14. G. H. Goossens and E. E. Blaak, "Adipose tissue dysfunction and impaired metabolic health in human obesity: a matter of oxygen?" Frontiers in Endocrinology, vol. 6, article 55, 2015.
15. G. H. Goossens, A. Bizzarri, N. Venteclef et al., "Increased adipose tissue oxygen tension in obese compared with lean men is accompanied by insulin resistance, impaired adipose tissue capillarization, and infammation," Circulation, vol. 124, no. 1, pp. 67-76, 2011.
16. L. Hodson, S. M. Humphreys, F. Karpe, and K. N. Frayn, "Metabolic signatures of human adipose tissue hypoxia in obesity," Diabetes, vol. 62, no. 5, pp. 1417-1425, 2013.
17. F. J. Lippl, S. Neubauer, S. Schipfer et al., "Hypobaric hypoxia causes body weight reduction in obese subjects," Obesity, vol. 18, no. 4, pp. 675-681, 2010.
18. K. R. Westerterp, "Energy and water balance at high altitude," News in Physiological Sciences, vol. 16, no. 3, pp. 134-137, 2001.
19. H.-C. Gunga, D. Fries, E. Humpeler et al., "Austrian Moderate Altitude Study (AMAS 2000)-fuid shifs, erythropoiesis, and angiogenesis in patients with metabolic syndrome at moderate altitude (≅1700 m)," European Journal of Applied Physiology, vol. 88, no. 6, pp. 497-505, 2003.
20. A. M. W. J. Schols and K. R. Westerterp, "Hypoxia, nitrogen balance and body weight," The European Respiratory Journal, vol. 20, no. 2, pp. 252-253, 2002.
21. P. González-Muniesa, P. Quintero, J. De Andŕes, and J. A. Martínez, "Hypoxia: a consequence of obesity and also a tool to treat excessive weight loss," Sleep & Breathing, vol. 19, no. 1, pp. 7-8, 2015.
22. P. Trayhurn, "Hypoxia and adipose tissue function and dysfunction in obesity," Physiological Reviews, vol. 93, no. 1, pp. 1-21, 2013.
23. R. Medzhitov, "Origin and physiological roles of infammation," Nature, vol. 454, no. 7203, pp. 428-435, 2008.
24. J. A. Martinez, P. Cordero, J. Campion, and F. I. Milagro, "Interplay of early-life nutritional programming on obesity, infammation and epigenetic outcomes," Proceedings of the Nutrition Society, vol. 71, no. 2, pp. 276-283, 2012.
25. S. Nayadu, G. Kaur, G. Gudi, and V. Addepalli, "The potentials of selected therapeutic targets for infammation: a snapshot," Recent Patents on Infammation and Allergy Drug Discovery, vol. 6, no. 2, pp. 137-146, 2012.
26. K. S. vel Szic, M. N. Ndlovu, G. Haegeman, and W. V. Berghe, "Nature or nurture: let food be your epigenetic medicine in chronic infammatory disorders," Biochemical Pharmacology, vol. 80, no. 12, pp. 1816-1832, 2010.
27. A. González-Chávez, S. Elizondo-Argueta, G. Gutiérrez-Reyes, and J. I. León-Pedroza, "Pathophysiological implications between chronic infammation and the development of diabetes and obesity," Cirugia y Cirujanos, vol. 79, no. 2, pp. 209-216, 2011.
28. S. Sun, Y. Ji, S. Kersten, and L. Qi, "Mechanisms of infammatory responses in obese adipose tissue," Annual Review of Nutrition, vol. 32, pp. 261-286, 2012.
29. P. Trayhurn, B. Wang, and I. S. Wood, "Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity?" British Journal of Nutrition, vol. 100, no. 2, pp. 227-235, 2008.
30. K. Fjeldborg, S. B. Pedersen, H. J. Møller, T. Christiansen, M. Bennetzen, and B. Richelsen, "Human adipose tissue macrophages are enhanced but changed to an anti-infammatory profle in obesity," Journal of Immunology Research, vol. 2014, Article ID 309548, 10 pages, 2014.
31. M. G. Farb, S. Bigornia, M. Mott et al., "Reduced adipose tissue infammation represents an intermediate cardiometabolic phe-notype in obesity," Journal of the American College of Cardiology, vol. 58, no. 3, pp. 232-237, 2011.
32. S. Talmann and C. A. Meier, "Local adipose tissue depots as cardiovascular risk factors," Cardiovascular Research, vol. 75, no. 4, pp. 690-701, 2007.
33. S. P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R. L. Leibel, and A. W. Ferrante Jr., "Obesity is associated with macrophage accumulation in adipose tissue," The Journal of Clinical Investigation, vol. 112, no. 12, pp. 1796-1808, 2003.
34. J. A. Bell, M. Kivimaki, and M. Hamer, "Metabolically healthy obesity and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies," Obesity Reviews, vol. 15, no. 6, pp. 504-515, 2014.
35. E. Navarro, A. N. Funtikova, M. Fíto, and H. Schröder, "Can metabolically healthy obesity be explained by diet, genetics, and infammation?" Molecular Nutrition & Food Research, vol. 59, no. 1, pp. 75-93, 2015.
36. J. Z. Ilich, O. J. Kelly, Y. Kim, and M. T. Spicer, "Low-grade chronic infammation perpetuated by modern diet as a promoter of obesity and osteoporosis," Archives of Industrial Hygiene and Toxicology, vol. 65, no. 2, pp. 139-148, 2014.
37. G. Marrazzo, I. Barbagallo, F. Galvano et al., "Role of dietary and endogenous antioxidants in diabetes," Critical Reviews in Food Science and Nutrition, vol. 54, no. 12, pp. 1599-1616, 2014.
38. V. D'Souza, P. Chavan-Gautam, and S. Joshi, "Counteracting oxidative stress in pregnancy through modulation of maternal micronutrients and omega-3 fatty acids," Current Medicinal Chemistry, vol. 20, no. 37, pp. 4777-4783, 2013.
39. S. Le Lay, G. Simard, M. C. Martinez, and R. Andriantsitohaina, "Oxidative stress and metabolic pathologies: from an adipocen-tric point of view," Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 908539, 18 pages, 2014.
40. U. Ö zcan, Q. Cao, E. Yilmaz et al., "Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes," Science, vol. 306, no. 5695, pp. 457-461, 2004.
41. I. S. Wood, F. P. de Heredia, B. Wang, and P. Trayhurn, "Cellular hypoxia and adipose tissue dysfunction in obesity," The Proceedings of the Nutrition Society, vol. 68, no. 4, pp. 370-377, 2009.
42. I. Bondia-Pons, L. Ryan, and J. A. Martinez, "Oxidative stress and infammation interactions in human obesity," Journal of Physiology and Biochemistry, vol. 68, no. 4, pp. 701-711, 2012.
43. K. Lolmède, C. Dufaut, A. Zakarof-Girard, and A. Bouloumíe, "Immune cells in adipose tissue: key players in metabolic disorders," Diabetes & Metabolism, vol. 37, no. 4, pp. 283-290, 2011.
44. R. W. O'Rourke, A. E. White, M. D. Metcalf et al., "Hypoxia-induced infammatory cytokine secretion in human adipose tissue stromovascular cells," Diabetologia, vol. 54, no. 6, pp. 1480-1490, 2011.
45. T. Cramer and R. S. Johnson, "A novel role for the hypoxia inducible transcription factor HIF-1alpha: critical regulation of infammatory cell function," Cell Cycle, vol. 2, no. 3, pp. 192-193, 2003.
46. P. Quintero, P. González-Muniesa, D. F. García-Díaz, and J. A. Martínez, "Efects of hyperoxia exposure on metabolic markers and gene expression in 3T3-L1 adipocytes," Journal of Physiology and Biochemistry, vol. 68, no. 4, pp. 663-669, 2012.
47. S. Rocha, "Gene regulation under low oxygen: holding your breath for transcription," Trends in Biochemical Sciences, vol. 32, no. 8, pp. 389-397, 2007.
48. J. Ye, Z. Gao, J. Yin, and Q. He, "Hypoxia is a potential risk factor for chronic infammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice," The American Journal of Physiology-Endocrinology and Metabolism, vol. 293, no. 4, pp. E1118-E1128, 2007.
49. B. Wang, I. S. Wood, and P. Trayhurn, "Dysregulation of the expression and secretion of infammation-related adipokines by hypoxia in human adipocytes," Pfügers Archiv-European Journal of Physiology, vol. 455, no. 3, pp. 479-492, 2007.
50. S. Famulla, A. Horrighs, A. Cramer, H. Sell, and J. Eckel, "Hypoxia reduces the response of human adipocytes towards TNFβ resulting in reduced NF-βB signaling and MCP-1 secretion," International Journal of Obesity, vol. 36, no. 7, pp. 986-992, 2012.
51. N. Ferrara, H.-P. Gerber, and J. LeCouter, "The biology of VEGF and its receptors," Nature Medicine, vol. 9, no. 6, pp. 669-676, 2003.
52. B. Blouw, H. Song, T. Tihan et al., "The hypoxic response of tumors is dependent on their microenvironment," Cancer Cell, vol. 4, no. 2, pp. 133-146, 2003.
53. B. Chen, K. S. L. Lam, Y. Wang et al., "Hypoxia dysregulates the production of adiponectin and plasminogen activator inhibitor-1 independent of reactive oxygen species in adipocytes," Biochemical and Biophysical Research Communications, vol. 341, no. 2, pp. 549-556, 2006.
54. S. Famulla, R. Schlich, H. Sell, and J. Eckel, "Diferentiation of human adipocytes at physiological oxygen levels results in increased adiponectin secretion and isoproterenol-stimulated lipolysis," Adipocyte, vol. 1, no. 3, pp. 132-181, 2014.
55. I. Mack, R. S. BelAiba, T. Djordjevic, A. Görlach, H. Hauner, and B. L. Bader, "Functional analyses reveal the greater potency of preadipocytes compared with adipocytes as endothelial cell activator under normoxia, hypoxia, and TNFalpha exposure," The American Journal of Physiology-Endocrinology and Metabolism, vol. 297, no. 3, pp. E735-E748, 2009.
56. B. Wang, I. S. Wood, and P. Trayhurn, "PCR arrays identify metallothionein-3 as a highly hypoxia-inducible gene in human adipocytes," Biochemical and Biophysical Research Communications, vol. 368, no. 1, pp. 88-93, 2008.
57. Q. Yao, M.-K. Shin, J. C. Jun et al., "Efect of chronic intermittent hypoxia on triglyceride uptake in diferent tissues," Journal of Lipid Research, vol. 54, no. 4, pp. 1058-1065, 2013.
58. K. Geiger, A. Leiherer, A. Muendlein et al., "Identifcation of hypoxia-induced genes in human SGBS adipocytes by microar-ray analysis," PLoS ONE, vol. 6, no. 10, Article ID e26465, 2011.
59. D. Mazzatti, F.-L. Lim, A. O'Hara, I. S. Wood, and P. Trayhurn, "A microarray analysis of the hypoxia-induced modulation of gene expression in human adipocytes," Archives of Physiology and Biochemistry, vol. 118, no. 3, pp. 112-120, 2012.
60. K. M. Oliver, J. F. Garvey, C. T. Ng et al., "Hypoxia activates NF-βB-dependent gene expression through the canonical signaling pathway," Antioxidants and Redox Signaling, vol. 11, no. 9, pp. 2057-2064, 2009.
61. 2 homeostasis," Current Opinion in Genetics and Development, vol. 8, no. 5, pp. 588-594, 1998.
62. M. C. Brahimi-Horn and J. Pouysségur, "Oxygen, a source of life and stress," FEBS Letters, vol. 581, no. 19, pp. 3582-3591, 2007.
63. G. L. Semenza, "HIF-1 and mechanisms of hypoxia sensing," Current Opinion in Cell Biology, vol. 13, no. 2, pp. 167-171, 2001.
64. S. Kushal, B. B. Lao, L. K. Henchey et al., "Protein domain mimetics as in vivo modulators of hypoxia-inducible factor signaling," Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 39, pp. 15602-15607, 2013.
65. M. Lawton, M. Tong, F. Gundogan, J. R. Wands, and S. M. De La Monte, "Aspartyl-(asparaginyl) beta-hydroxylase, hypoxia-inducible factor-alpha and Notch cross-talk in regulating neuronal motility," Oxidative Medicine and Cellular Longevity, vol. 3, no. 5, pp. 347-356, 2010.
66. Z. E. Floyd, G. Kilroy, X. Wu, and J. M. Gimble, "Efects of prolyl hydroxylase inhibitors on adipogenesis and hypoxia inducible factor 1 alpha levels under normoxic conditions," Journal of Cellular Biochemistry, vol. 101, no. 6, pp. 1545-1557, 2007.
67. X. M. Leverve, "To cope with oxygen: a long and still tumultuous story for life," Critical Care Medicine, vol. 36, no. 2, pp. 637-638, 2008.
68. P. Quintero, F. I. Milagro, J. Campión, and J. A. Martínez, "Impact of oxygen availability on body weight management," Medical Hypotheses, vol. 74, no. 5, pp. 901-907, 2010.
69. P. Quintero, P. González-Muniesa, and J. A. Martínez, "Infu-ence of diferent oxygen supply on metabolic markers and gene response in murine adipocytes," Journal of Biological Regulators and Homeostatic Agents, vol. 26, no. 3, pp. 379-388, 2012.
70. A.-S. A. Hafor and O. S. Alttas, "Efects of exposure of rats to periodic versus continuous hyperoxia on antioxidant potentials and free radical production in relation to ultrastructural changes in myocardial cells," Inhalation Toxicology, vol. 22, no. 10, pp. 797-804, 2010.
71. M. S. Arkovitz, C. Szabó, V. F. Garcia, H. R. Wong, and J. R. Wispé, "Diferential efects of hyperoxia on the inducible and constitutive isoforms of nitric oxide synthase in the lung," Shock, vol. 7, no. 5, pp. 345-350, 1997.
72. W. P. Daugherty, J. E. Levasseur, D. Sun, G. L. Rockswold, and M. R. Bullock, "Efects of hyperbaric oxygen therapy on cerebral oxygenation and mitochondrial function following moderate lateral fuid-percussion injury in rats," Journal of Neurosurgery, vol. 101, no. 3, pp. 499-504, 2004.
73. S. J. Hughes, W. Yang, M. Juszczak et al., "Efect of inspired oxygen on portal and hepatic oxygenation: efective arterialization of portal blood by hyperoxia," Cell Transplantation, vol. 13, no. 7-8, pp. 801-808, 2004.
74. S. R. Tom, "Hyperbaric oxygen: its mechanisms and efcacy," Plastic and Reconstructive Surgery, vol. 127, no. 1, pp. 131S-141S, 2011.
75. P. Desmarquest, K. Chadelat, S. Corroyer, V. Cazals, and A. Clement, "Efect of hyperoxia on human macrophage cytokine response," Respiratory Medicine, vol. 92, no. 7, pp. 951-960, 1998.
76. N. S. Al-Waili, G. J. Butler, J. Beale et al., "Infuences of hyper-baric oxygen on blood pressure, heart rate and blood glucose levels in patients with diabetes mellitus and hypertension," Archives of Medical Research, vol. 37, no. 8, pp. 991-997, 2006.
77. D. De Bels, F. Corazza, P. Germonpŕe, and C. Balestra, "The normobaric oxygen paradox: a novel way to administer oxygen as an adjuvant treatment for cancer?" Medical Hypotheses, vol. 76, no. 4, pp. 467-470, 2011.
78. H. D. Wilson, J. R. Wilson, and P. N. Fuchs, "Hyperbaric oxygen treatment decreases infammation and mechanical hypersensi-tivity in an animal model of infammatory pain," Brain Research, vol. 1098, no. 1, pp. 126-128, 2006.
79. E. H. H. Chiu, C.-S. Liu, T.-Y. Tan, and K.-C. Chang, "Venturi mask adjuvant oxygen therapy in severe acute ischemic stroke," Archives of Neurology, vol. 63, no. 5, pp. 741-744, 2006.
80. A. B. Singhal, T. Banner, L. Roccatagliata et al., "A pilot study of normobaric oxygen therapy in acute ischemic stroke," Stroke, vol. 36, no. 4, pp. 797-802, 2005.
81. L. Sun, H. Strelow, G. Mies, and R. Veltkamp, "Oxygen therapy improves energy metabolism in focal cerebral ischemia," Brain Research, vol. 1415, pp. 103-108, 2011.
82. H. Kato, J. Araki, K. Doi et al., "Normobaric hyperoxygenation enhances initial survival, regeneration, and fnal retention in fat grafing," Plastic and Reconstructive Surgery, vol. 134, no. 5, pp. 951-959, 2014.
83. F. L. Contreras, M. Kadekaro, and H. M. Eisenberg, "The efect of hyperbaric oxygen on glucose utilization in a freeze-traumatized rat brain," Journal of Neurosurgery, vol. 68, no. 1, pp. 137-141, 1988.
84. V. Roth, M. S. Herron, R. A. Bueno Jr., C. B. Chambers, and M. W. Neumeister, "Stimulating angiogenesis by Hyperbaric oxygen in an isolated tissue construct," Undersea & Hyperbaric Medicine, vol. 38, no. 6, pp. 509-514, 2011.
85. D. Wilkinson, I. M. Chapman, and L. K. Heilbronn, "Hyper-baric oxygen therapy improves peripheral insulin sensitivity in humans," Diabetic Medicine, vol. 29, no. 8, pp. 986-989, 2012.
86. J. W. Calvert, J. Cahill, M. Yamaguchi-Okada, and J. H. Zhang, "Oxygen treatment afer experimental hypoxia-ischemia in neonatal rats alters the expression of HIF-1β and its downstream target genes," Journal of Applied Physiology, vol. 101, no. 3, pp. 853-865, 2006.
87. A. B. Singhal, E. Ratai, T. Benner et al., "Magnetic resonance spectroscopy study of oxygen therapy in ischemic stroke," Stroke, vol. 38, no. 10, pp. 2851-2854, 2007.
88. L. Huang and A. Obenaus, "Hyperbaric oxygen therapy for traumatic brain injury," Medical Gas Research, vol. 1, no. 1, p. 21, 2011.
89. M. H. Bennett, C. French, A. Schnabel, J. Wasiak, and P. Kranke, "Normobaric and hyperbaric oxygen therapy for migraine and cluster headache," Cochrane Database of Systematic Reviews, no. 3, Article ID CD005219, 2008.
90. M. H. Bennett, J. Feldmeier, N. Hampson, R. Smee, and C. Milross, "Hyperbaric oxygen therapy for late radiation tissue injury," Cochrane Database of Systematic Reviews, vol. 3, Article ID CD005005, 2012.
91. S. Kaur, M. Pawar, N. Banerjee, and R. Garg, "Evaluation of the efcacy of hyperbaric oxygen therapy in the management of chronic nonhealing ulcer and role of periwound transcutaneous oximetry as a predictor of wound healing response: a randomized prospective controlled trial," Journal of Anaesthesiology Clinical Pharmacology, vol. 28, no. 1, pp. 70-75, 2012.
92. L. Ma, P. Li, Z. Shi, T. Hou, X. Chen, and J. Du, "A prospective, randomized, controlled study of hyperbaric oxygen therapy: efects on healing and oxidative stress of ulcer tissue in patients with a diabetic foot ulcer," Ostomy/Wound Management, vol. 59, no. 3, pp. 18-24, 2013.
93. Z. Peng, S. Wang, X. Huang, and P. Xiao, "Efect of hyperbaric oxygen therapy on patients with herpes zoster," Undersea and Hyperbaric Medicine, vol. 39, no. 6, pp. 1083-1087, 2012.
94. A. Y. Sheikh, J. J. Gibson, M. D. Rollins, H. W. Hopf, Z. Hussain, and T. K. Hunt, "Efect of hyperoxia on vascular endothelial growth factor levels in a wound model," Archives of Surgery, vol. 135, no. 11, pp. 1293-1297, 2000.
95. M. L. Edwards, "Hyperbaric oxygen therapy. Part 2: application in disease," Journal of Veterinary Emergency and Critical Care, vol. 20, no. 3, pp. 289-297, 2010.
96. A. B. Singhal, "A review of oxygen therapy in ischemic stroke," Neurological Research, vol. 29, no. 2, pp. 173-183, 2007.
97. Z. Zhang, X. Bai, K. Du et al., "Activation of cholinergic anti-infammatory pathway contributes to the protective efects of 100% oxygen inhalation on zymosan-induced generalized infammation in mice," The Journal of Surgical Research, vol. 174, no. 2, pp. e75-e83, 2012.
98. L.-L. Chiu, S.-W. Chou, Y.-M. Cho et al., "Efect of prolonged intermittent hypoxia and exercise training on glucose tolerance and muscle GLUT4 protein expression in rats," Journal of Biomedical Science, vol. 11, no. 6, pp. 838-846, 2004.
99. B. van den Borst, A. M. W. J. Schols, C. de Teije et al., "Characterization of the infammatory and metabolic profle of adipose tissue in a mouse model of chronic hypoxia," Journal of Applied Physiology, vol. 114, no. 11, pp. 1619-1628, 2013.
100. R. Mackenzie, N. Maxwell, P. Castle, G. Brickley, and P. Watt, "Acute hypoxia and exercise improve insulin sensitivity (S(I) (2∗)) in individuals with type 2 diabetes," Diabetes/Metabolism Research and Reviews, vol. 27, no. 1, pp. 94-101, 2011.
101. V. Lecoultre, C. M. Peterson, J. D. Covington et al., "Ten nights of moderate hypoxia improves insulin sensitivity in obese humans," Diabetes Care, vol. 36, no. 12, pp. e197-e198, 2013.
102. Z. Kong, Y. Zang, and Y. Hu, "Normobaric hypoxia training causes more weight loss than normoxia training afer a 4-week residential camp for obese young adults," Sleep & Breathing, vol. 18, no. 3, pp. 591-597, 2014.
103. P. González-Muniesa, C. de Oliveira, F. Pérez de Heredia, M. P. Tompson, and P. Trayhurn, "Fatty acids and hypoxia stimulate the expression and secretion of the adipokine ANGPTL4 (angiopoietin-like protein 4/ fasting-induced adipose factor) by human adipocytes," Journal of Nutrigenetics and Nutrigenomics, vol. 4, no. 3, pp. 146-153, 2011.
104. P. González-Muniesa, A. Lopez-Pascual, J. de Andŕes et al., "Impact of intermittent hypoxia and exercise on blood pressure and metabolic features from obese subjects sufering sleep apnea-hypopnea syndrome," Journal of Physiology and Biochemistry, vol. 71, no. 3, pp. 589-599, 2015.
105. H. Gatterer, S. Haacke, M. Burtscher et al., "Normobaric intermittent hypoxia over 8 months does not reduce body weight and metabolic risk factors-a randomized, single blind, placebo-controlled study in normobaric hypoxia and normobaric sham hypoxia," Obesity Facts, vol. 8, no. 3, pp. 200-209, 2015.
106. M. St-Onge and A. Shechter, "Sleep disturbances, body fat distribution, food intake and/or energy expenditure: patho-physiological aspects," Hormone Molecular Biology and Clinical Investigation, vol. 17, no. 1, pp. 29-37, 2014.
107. B. A. Edwards, S. A. Sands, R. L. Owens et al., "Efects of hyperoxia and hypoxia on the physiological traits responsible for obstructive sleep apnoea," The Journal of Physiology, vol. 592, no. 20, pp. 4523-4535, 2014.
108. G. S. Zavorsky and S. L. Hofman, "Pulmonary gas exchange in the morbidly obese," Obesity Reviews, vol. 9, no. 4, pp. 326-339, 2008.
109. A. C. Kendall, J. L. Whatmore, L. W. Harries, P. G. Winyard, G. R. Smerdon, and P. Eggleton, "Changes in infammatory gene expression induced by hyperbaric oxygen treatment in human endothelial cells under chronic wound conditions," Experimental Cell Research, vol. 318, no. 3, pp. 207-216, 2012.
110. H. Li, Z.-Z. Zhang, J. Zhan, X.-H. He, X.-M. Song, and Y.-L. Wang, "Protective efect of PNU-120596, a selective alpha7 nicotinic acetylcholine receptor-positive allosteric modulator, on myocardial ischemia-reperfusion injury in rats," Journal of Cardiovascular Pharmacology, vol. 59, no. 6, pp. 507-513, 2012.
111. C. Yzydorczyk, B. Comte, G. Cambonie et al., "Neonatal oxygen exposure in rats leads to cardiovascular and renal alterations in adulthood," Hypertension, vol. 52, no. 5, pp. 889-895, 2008.
112. G.F. Benderro, X. Sun, Y. Kuang, and J.C. Lamanna, "Decreased VEGF expression and microvascular density, but increased HIF-1 and 2alpha accumulation and EPO expression in chronic moderate hyperoxia in the mouse brain," Brain Research, vol. 1471, pp. 46-55, 2012.
113. Y. S. Chang, S. J. Choi, S. Y. Ahn et al., "Timing of umbilical cord blood derived mesenchymal stem cells transplantation determines therapeutic efcacy in the neonatal hyperoxic lung injury," PLoS ONE, vol. 8, no. 1, Article ID e52419, 2013.
114. J. C. Jensen, H. W. Pogrebniak, H. I. Pass et al., "Role of tumor necrosis factor in oxygen toxicity," Journal of Applied Physiology, vol. 72, no. 5, pp. 1902-1907, 1992.
115. A. Bellmeyer, J. M. Martino, N. S. Chandel, G. R. S. Budinger, D. A. Dean, and G. M. Mutlu, "Leptin resistance protects mice from hyperoxia-induced acute lung injury," American Journal of Respiratory and Critical Care Medicine, vol. 175, no. 6, pp. 587-594, 2007.
116. C. Barazzone-Argirofo, P. Muzzin, Y. R. Donati, C.-D. Kan, M. L. Aubert, and P.-F. Piguet, "Hyperoxia increases leptin production: a mechanism mediated through endogenous elevation of corticosterone," American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 281, no. 5, pp. L1150-L1156, 2001.
117. N. Lahat, H. Bitterman, N. Yaniv, A. Kinarty, and N. Bitterman, "Exposure to hyperbaric oxygen induces tumour necrosis factor-alpha (TNF-β) secretion from rat macrophages," Clinical & Experimental Immunology, vol. 102, no. 3, pp. 655-659, 1995.
118. G. D. Marconi, S. Zara, M. De Colli et al., "Postnatal hyperoxia exposure diferentially afects hepatocytes and liver haemopoi-etic cells in newborn rats," PLoS ONE, vol. 9, no. 8, Article ID e105005, 2014.
119. D. J. Kwak, S. D. Kwak, and E. B. Gauda, "The efect of hyperoxia on reactive oxygen species (ROS) in petrosal and nodose ganglion neurons during development (using organotypic slices)," Advances in Experimental Medicine and Biology, vol. 580, pp. 111-114, 2006.
120. C. Brueckl, S. Kaestle, A. Kerem et al., "Hyperoxia-induced reactive oxygen species formation in pulmonary capillary endothelial cells in situ," American Journal of Respiratory Cell and Molecular Biology, vol. 34, no. 4, pp. 453-463, 2006.
121. Q. Zangl, A. Martignoni, S. H. Jackson et al., "Postoperative hyperoxia (60%) worsens hepatic injury in Mice," Anesthesiol-ogy, vol. 121, no. 6, pp. 1217-1225, 2014.
122. B. Adamcio, S. Sperling, N. Hagemeyer, G. Walkinshaw, and H. Ehrenreich, "Hypoxia inducible factor stabilization leads to lasting improvement of hippocampal memory in healthy mice," Behavioural Brain Research, vol. 208, no. 1, pp. 80-84, 2010.
123. S. R. Tom, "Oxidative stress is fundamental to hyperbaric oxygen therapy," Journal of Applied Physiology, vol. 106, no. 3, pp. 988-995, 2009.
124. Y. Quan, C.-T. Jiang, B. Xue, S.-G. Zhu, and X. Wang, "High glucose stimulates TNFβ and MCP-1 expression in rat microglia via ROS and NF-βB pathways," Acta Pharmacologica Sinica, vol. 32, no. 2, pp. 188-193, 2011.
125. F. Mattijssen and S. Kersten, "Regulation of triglyceride metabolism by Angiopoietin-like proteins," Biochimica et Biophysica Acta, vol. 1821, no. 5, pp. 782-789, 2012.
126. T. Yamada, N. Ozaki, Y. Kato, Y. Miura, and Y. Oiso, "Insulin downregulates angiopoietin-like protein 4 mRNA in 3T3-L1 adipocytes," Biochemical and Biophysical Research Communications, vol. 347, no. 4, pp. 1138-1144, 2006.
127. K. Rooney and P. Trayhurn, "Lactate and the GPR81 receptor in metabolic regulation: implications for adipose tissue function and fatty acid utilisation by muscle during exercise," The British Journal of Nutrition, vol. 106, no. 9, pp. 1310-1316, 2011.
128. I. Ismail, S. E. Keating, M. K. Baker, and N. A. Johnson, "A systematic review and meta-analysis of the efect of aerobic vs. resistance exercise training on visceral fat," Obesity Reviews, vol. 13, no. 1, pp. 68-91, 2012.